跳至主要内容
临床试验/NL-OMON50584
NL-OMON50584招募中不适用

Reirradiation for recurrent lung cancer in the thorax: overall survival, local control, and toxicity: a phase 2 trial - RETHO

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 63 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
63

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • The patients have the tumor close (5 cm or less) to the high dose region (50 Gy
  • EQD2 or more) of the previous irradiation.
  • Minimal interval between initial treatment with curative intent and
  • reirradiation of 9 months. Treatment in radical setting (at least 45 Gy EQD2)
  • must be possible according to the local investigator.
  • Treatment options for the patient will be discussed at multidisciplinary
  • oncology board.
  • Karnofsky score * 70

排除标准

  • Patients with more than 3 (oligo)metastases and/or (oligo)metastasis in more
  • than 2 organs and/or (oligo)metastasis which cannot be treated locally.
  • Inability to retrieve the previous radiation fields, total dose, dose per
  • fraction and time of first radiation series and DVH of the organs at risk.
  • Not possible to use intervenous CT-contrast.
  • Pregnant woman.
  • The use of radiosensitizers such as plaquenil.

研究者

相似试验